clinical trials

AI is transforming clinical trials by predicting success with 90% accuracy. This could lead to fewer trials, better outcomes, and reduced trial times. Companies like OPYL, OpenAI, and Moderna are at the forefront of this AI-driven healthcare revolution. Using 20 years of past clinical trial data, OPYL can improve trial outcomes by 4 to 5 times, reducing costs and improving success.

Within a decade we will cure disease, not just treat it. AI accelerates drug discovery and will reduce cost of new drugs by 4 from $2.4 billion to $600 million, and time from 14 years to 6 years. ROI improves 12 times. AI in medicine will not just improve medicines but will improve diagnosis and treatment.